Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

被引：0
|
作者：
Boris Kovatchev
Zhaoling Meng
Anna M. G. Cali
Riccardo Perfetti
Marc D. Breton
机构：
[1] University of Virginia,Center for Diabetes Technology
[2] Sanofi,undefined
[3] Sanofi,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Basal insulin; Glycaemic variability; Hypoglycaemia; Insulin glargine; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1293 / 1302
页数：9
相关论文
共 50 条
  • [31] EVALUATION OF PATIENT REPORTED SATISFACTION AND CLINICAL EFFICACY OF INSULIN GLARGINE 300 U/ML VERSUS 100 U/ML IN PATIENTS WITH TYPE 1 DIABETES
    Al Hayek, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A104 - A105
  • [32] Similar glycaemic control and less or comparable hypoglycaemia with insulin glargine 300 U/ml vs degludec 100 U/ml in insulin naive type 2 diabetes: the BRIGHT randomised study
    Cheng, A.
    Rosenstock, J.
    Ritzel, R.
    Bosnyak, Z.
    Devisme, C.
    Stella, P.
    Cali, A. M. G.
    Wang, X.
    Frias, J.
    Roussel, R.
    Bolli, G. B.
    [J]. DIABETOLOGIA, 2018, 61 : S42 - S42
  • [33] Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus
    Linari, Guido
    Fleeman, Linda
    Gilor, Chen
    Giacomelli, Lucia
    Fracassi, Federico
    [J]. JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (02) : 168 - 176
  • [34] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [35] New insulin glargine 300U/ml in people with Type 2 diabetes using basal insulin plus oral glucose lowering drugs compared with glargine 100U/ml (EDITION 2): less nocturnal hypoglycaemia and weight gain
    Home, P. D.
    Riddle, M. C.
    Bergenstal, R. M.
    Bolli, G. B.
    Wardecki, M.
    Maroccia, M.
    Yki-Jarvinen, H.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 79
  • [36] Comparative effectiveness of insulin glargine 300 U/mL and insulin degludec 100 U/mL in insulin naive type 2 diabetes adults: the Restore-2 naive cohort
    Fadini, G. P.
    Buzzetti, R.
    Larosa, M.
    Rossi, M. C.
    Nicolucci, A.
    Cucinotta, D.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 74 - 74
  • [37] Glycaemic control and hypoglycaemia during 12months of randomized treatment with insulin glargine 300U/mL versus glargine 100U/mL in people with type 1 diabetes (EDITION 4)
    Home, Philip D.
    Bergenstal, Richard M.
    Bolli, Geremia B.
    Ziemen, Monika
    Rojeski, Maria
    Espinasse, Melanie
    Riddle, Matthew C.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 121 - 128
  • [38] Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
    Ritzel, R.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Brulle-Wohlhueter, C.
    Glezer, S.
    Yki-Jaervinen, H.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 859 - 867
  • [39] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Maffeis, Claudio
    Rabbone, Ivana
    [J]. PEDIATRIC DRUGS, 2022, 24 (05) : 499 - 512
  • [40] Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/ml (Gla-300)
    Stella, P.
    Aroda, V.
    Charbonnel, B.
    Ritzel, R.
    Merino-Trigo, A.
    Grisoni, M. -L.
    Sinclair, A. J.
    Yale, J. -F.
    [J]. DIABETOLOGIA, 2015, 58 : S473 - S473
12345